The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(4-((2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)methyl)benzamido)cyclohexan-1-carboxylic acid ID: ALA4442032
PubChem CID: 155515740
Max Phase: Preclinical
Molecular Formula: C21H23N5O4
Molecular Weight: 409.45
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Nc1nc2[nH]cc(Cc3ccc(C(=O)NC4CCCCC4C(=O)O)cc3)c2c(=O)[nH]1
Standard InChI: InChI=1S/C21H23N5O4/c22-21-25-17-16(19(28)26-21)13(10-23-17)9-11-5-7-12(8-6-11)18(27)24-15-4-2-1-3-14(15)20(29)30/h5-8,10,14-15H,1-4,9H2,(H,24,27)(H,29,30)(H4,22,23,25,26,28)
Standard InChI Key: WBBNOYZOZAGYRQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
30 33 0 0 0 0 0 0 0 0999 V2000
3.7929 -20.2399 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.7929 -21.0571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4982 -21.4616 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.4982 -19.8272 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2035 -20.2399 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2079 -21.0536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9832 -21.3008 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.4579 -20.6399 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9759 -19.9843 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4982 -19.0100 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.0858 -21.4667 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.2242 -19.2057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0226 -19.0314 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5693 -19.6392 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3670 -19.4654 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6159 -18.6862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0610 -18.0805 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2653 -18.2574 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4141 -18.5108 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9650 -19.1143 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.6613 -17.7319 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.4602 -17.5624 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0034 -18.1720 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7993 -18.0051 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0560 -17.2295 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5106 -16.6203 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7084 -16.7868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1587 -16.1795 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4114 -15.4024 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.3594 -16.3493 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 4 1 0
2 3 2 0
3 6 1 0
5 4 1 0
5 6 2 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
4 10 2 0
2 11 1 0
9 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
16 19 1 0
19 20 2 0
19 21 1 0
21 22 1 0
22 23 1 0
22 27 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
28 29 1 0
28 30 2 0
27 28 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 409.45Molecular Weight (Monoisotopic): 409.1750AlogP: 1.80#Rotatable Bonds: 5Polar Surface Area: 153.96Molecular Species: ACIDHBA: 5HBD: 5#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 6#RO5 Violations (Lipinski): 1CX Acidic pKa: 4.20CX Basic pKa: 3.29CX LogP: 1.69CX LogD: -1.06Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.43Np Likeness Score: -0.17
References 1. Czyzyk DJ, Valhondo M, Deiana L, Tirado-Rives J, Jorgensen WL, Anderson KS.. (2019) Structure activity relationship towards design of cryptosporidium specific thymidylate synthase inhibitors., 183 [PMID:31536894 ] [10.1016/j.ejmech.2019.111673 ]